Stay updated on Efruxifermin in NASH Cirrhosis Clinical Trial
Sign up to get notified when there's something new on the Efruxifermin in NASH Cirrhosis Clinical Trial page.

Latest updates to the Efruxifermin in NASH Cirrhosis Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.3%
- Check17 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference6%
- Check25 days agoNo Change Detected
- Check46 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.3%
- Check61 days agoChange DetectedThe page has been updated to reflect a new version of a study related to Efruxifermin, changing from revision v2.14.4 to v2.15.0, along with an updated date.SummaryDifference2%
- Check68 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for February 26, 2025. However, the removal of the date for March 25, 2025, does not significantly impact the core content.SummaryDifference1.0%
- Check104 days agoChange DetectedThe page has updated the study date for Efruxifermin in subjects with compensated cirrhosis due to NASH from April 25, 2023, to February 26, 2025.SummaryDifference1%
Stay in the know with updates to Efruxifermin in NASH Cirrhosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efruxifermin in NASH Cirrhosis Clinical Trial page.